Results from the Scandinavian Obesity Surgery Registry: A narrative review

Abstract

SummaryIn 2007, the Scandinavian Obesity Surgery Registry (SOReg) was started by the profession to monitor the results of bariatric surgery and to provide a high‐quality database for research. In the end of August 2023, SOReg contains 88,379 patients (body mass index [BMI] 41.7 kg/m2, 41.2 years, 77.1% females, gastric bypass 76.8%). In this narrative review, we demonstrate that preoperative weight loss is of value and that the laparoscopic double omega‐loop technique is highly suitable for gastric bypass. Closing the mesenteric openings is, however, important. Swedish bariatric surgery has low mortality, and our results are comparative to those of other countries. Significant long‐term improvements are found in common obesity‐related diseases such as diabetes, hypertension, and sleep apnea. Furthermore, the risk for cardiac failure and major adverse cardiovascular events is significantly reduced. Pregnancy‐related outcomes are also improved. Gastric bypass results in significant improvements in quality of life and seems to be cost saving. We have revealed that low socioeconomic status is associated with reduced chance of undergoing bariatric surgery and inferior outcomes. Of note, we have performed several randomized clinical trials within the registry database. In conclusion, high‐quality national registry databases, such as SOReg, are important for maintaining high‐quality care and present a platform for extensive research.

Postoperative Dumping Syndrome, Health-Related Quality of Life, Anxiety, Depression, and Eating Disturbances: Results of a Longitudinal Obesity Surgery Study

“…Obesity surgery is the method of choice in the treatment of persistent severe adiposity and associated diseases such as type 2 diabetes mellitus, hypertension, and dyslipidemia [1][2][3][4][5][6][7]. In addition to sustained weight loss and positive effects on the patient's quality of life and mental health [7][8][9][10][11], surgery can also be associated with undesirable side effects.…”

Patients’ perioperative experiences of an opioid-free versus opioid-based care pathway for laparoscopic bariatric surgery: A qualitative study

“…Bariatric surgery is an effective long-term weight loss intervention for individuals with severe obesity. It not only showcases a reduction in the risks associated with comorbidities, such as diabetes type 2, obstructive sleep apnoea, hyperlipidaemia, hypertension, cancer, and cardiovascular disease, but also contributes to a significant improvement in health-related quality of life ( D'Hondt et al, 2011 ; Kolotkin et al, 2012 ; Singh et al, 2020 ; Sjöström et al, 2004 ; Sundbom et al, 2024 ). Internationally, the median age for patients undergoing bariatric surgery varies from 34 to 45 years, with 79 % being women ( International Federation for the Surgery of Obesity and Metabolic Disorders, 2023 ).…”